Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study

These findings demonstrate that polygenic VTE risk scores can identify patients with cancer with a 1.9-fold higher VTE risk independent of cancer type. Combined clinical-genetic scores to improve cancer-associated VTE prediction should be evaluated further.